{"id":"W2762636298","doi":"10.1093/annonc/mdx440.029","title":"CheckMate 214: Efficacy and safety of nivolumab + ipilimumab (N+I) v sunitinib (S) for treatment-naïve advanced or metastatic renal cell carcinoma (mRCC), including IMDC risk and PD-L1 expression subgroups","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Ipilimumab; Nivolumab; Gastroenterology; Sunitinib; Urology; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004281425,0.0002915198,0.0008651377,0.0002623764,0.0001908772,0.000610063,0.0003586476,0.0003777056,0.002625883],"category_scores_gemma":[0.0006978865,0.0001501407,0.0009096785,0.0001972362,0.0002107462,0.0004550148,0.000180687,0.0007529477,0.0003902605],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007998789,"about_ca_system_score_gemma":0.0006327454,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001023475,"about_ca_topic_score_gemma":0.003413376,"domain_scores_codex":[0.9998137,0.00005120592,0.0000171154,0.00004240026,0.00003168497,0.0000438038],"domain_scores_gemma":[0.9998106,0.00004221594,0.00004777206,0.0000214236,0.00001516508,0.00006284359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4811846,0.006012673,0.05013847,0.001087092,0.002804132,0.000220682,0.0001685828,0.004123698,0.05509678,0.0004842372,0.005003449,0.3936756],"study_design_scores_gemma":[0.1462438,0.3239689,0.401774,0.0002922086,0.01007208,0.002402283,0.0002842606,0.01703098,0.0744023,0.001146754,0.02215367,0.0002287226],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955693,0.002261994,0.0001187233,0.0001112527,0.00004472028,0.00005348509,0.0004023151,0.00006646718,0.001371704],"genre_scores_gemma":[0.9980898,0.0004510544,0.0001328873,0.0000859082,0.0000233776,0.00002693569,0.0004822784,0.00000810944,0.0006995971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002625883,"threshold_uncertainty_score":0.008784473,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1354962718192336,"score_gpt":0.3983821476230416,"score_spread":0.2628858758038081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}